About Q² Solutions
Q² Solutions is a Healthcare company based in Morrisville (United States) founded in 2015, and was acquired by IQVIA in April 2021. Laboratory services including central labs and biomarkers are provided. Q² Solutions has completed 1 acquisition, including Myriad RBM. Its chief executive, as recorded, is Costa Panagos. Its website q2labsolutions.com draws about 56 thousand monthly visits. Q² Solutions offers products and services including Central Laboratory Services, Labmatrix, Genomics Services, Discovery Sciences, and Bioanalytical Laboratories. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its competitors include BioAgilytix, Advion and Evans Analytical Group; 1 of its 3 listed competitors has raised funding.
Company details
Q2 solutions is a joint venture of Quintiles and Quest Diagnostics. The company provides all the laboratory services which include newly integrated central laboratories (assay development, flow cytometry services, specimen management, biobanking, and lab data management), bioanalytical and ADME laboratories, anatomic pathology, genomics (bioinformatics, DNARNA services), biomarkers, precision medicine, companion diagnostics, and vaccine testing services. It uses Quintiles proprietary technology Quintiles Infosario for data analysis and integration, The company partners with other CROs to provided end to end solutions to their customers.
- Headquarters Morrisville, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website q2labsolutions.com
- Social LinkedIn X
- Acquired by IQVIA (Apr 2021)
- Investors
- Investments & Acquisitions
- Acquired byIQVIA
(Apr 2021)
Products & Services of Q² Solutions
Q² Solutions offers a comprehensive portfolio of products and services, including Central Laboratory Services, Labmatrix, Genomics Services, Discovery Sciences, and Bioanalytical Laboratories.
Provides testing for drug and diagnostics development in trials.
Manages clinical trial samples and data securely online.
Supports drug discovery through sequencing and biomarker assays.
Offers protein and antibody discovery for early development.
Conducts assays for small molecules and immunogenicity testing.
Investors in Q² Solutions
Q² Solutions has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include IQVIA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical research and commercialization solutions are provided for healthcare. | 1982 | iqvia.com | Durham, United States |
Investor details for Q Solutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Q² Solutions
1270 people are tracked at Q² Solutions (702 in leadership, 9 in board & advisors, 559 in team).
| Name | Role | Group |
|---|---|---|
Costa Panagos | CEO | Leadership |
Peter Scilipote | Vice President, Business Transformation | Leadership |
Lynda Curtin | Director Clinical Operations -site Management | Leadership |
Oana Borse | Director, Strategic Sourcing R&ds | Leadership |
David Peig | Senior Director - Rare Disease BU & GTM Strategy | Leadership |
Mike Davis | Sr. Director, Strategic Business Development (r&d Solutions) | Leadership |
Ryan Deterding | Vice President And Global Account Director | Leadership |
Iqbal Thaker | Assoc. Director - IT Projects | Leadership |
Jennifer Millard | Vice President | Leadership |
Arthur Jenkins | Senior Director, Porfolio Project Management And Development Engineering | Leadership |
Manoj Singh | Director Of Software Engineering | Leadership |
Ester Pavon | Associate Director, Clinical Project Management | Leadership |
Nuno Dias | Senior Director, IT (head Of Technology) | Leadership |
Alexey Levashov | Associate Clinical Project Management Director | Leadership |
Chris Nickum | Vice President And General Manager, Commercial Solutions And Insights Hub (csih) | Leadership |
Fumihiko Ugajin | President - Japan | Leadership |
Stormie R. Crouch | Senior Director, Business Development | Leadership |
Avery Pasch | Account Director | Leadership |
Abbygail Boswell | International Project Associate Director | Leadership |
Susan Grant Schneider | Senior Vice President | Leadership |
1250 more people are available in the full profile.
Complete people profiles for Q² Solutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Q² Solutions
Q² Solutions has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Myriad RBM.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Multiplexed immunoassay testing is conducted by the laboratory in Austin. | myriadrbm.com | Austin, United States | 2002 | May 2021 | •••• |
Complete acquisition details for Q Solutions
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Q² Solutions
3 dated milestones of Q² Solutions across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Q² Solutions is founded.
- Exit Acquired by IQVIA.
- Acquisition Acquires Myriad RBM.
Competitors of Q² Solutions
Q² Solutions has 3 listed competitors in our database, 1 of them funded. They include BioAgilytix, Advion and Evans Analytical Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioagilytix.com | 2008 | Durham, United States | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | ||
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| eag.com | 1978 | San Diego, United States | 601 | Company offering a suite of scientific services for materials, engineering, agri, and life science industries |
Detailed competitors of Q Solutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Q² Solutions
The website of Q² Solutions (q2labsolutions.com) receives about 56K visits a month and ranks #486,852 among all websites worldwide, #473 in Biotechnology and Pharmaceuticals.
- Monthly visits56K
▲ 8.9% vs previous month
- Unique visitors13.8K
per month
- Global rank#486,852
among all websites
- Category rank#473
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit5.0
- Average visit2 min 55 sec
- DevicesDesktop 83% · Mobile 17%
Websites whose visitors overlap most with Q² Solutions. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cirbi.net | cirbi.net | 100% | #187,438 | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Q² Solutions (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Q² Solutions
Complete news archive for Q Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Q² Solutions
Q² Solutions was founded in 2015.
Q² Solutions is headquartered in Morrisville, United States.
Costa Panagos is the CEO of Q² Solutions, as recorded in our data.
Q2 solutions is a joint venture of Quintiles and Quest Diagnostics. The company provides all the laboratory services which include newly integrated central laboratories (assay development, flow cytometry services, specimen management, biobanking, and lab data management), bioanalytical and ADME laboratories, anatomic pathology, genomics (bioinformatics, DNARNA services), biomarkers, precision medicine, companion diagnostics, and vaccine testing services. It uses Quintiles proprietary technology Quintiles Infosario for data analysis and integration, The company partners with other CROs to provided end to end solutions to their customers.
Q² Solutions's top competitors include BioAgilytix, Advion and Evans Analytical Group.
Q² Solutions offers Central Laboratory Services, Labmatrix, Genomics Services, Discovery Sciences, and Bioanalytical Laboratories.
Q² Solutions has made 1 acquisition, including Myriad RBM.
Q² Solutions has 1 investor. Key investors include IQVIA.
Yes. Q² Solutions was acquired by IQVIA in April 2021.